SlideShare ist ein Scribd-Unternehmen logo
1 von 14
NATIONAL PHARMACEUTICAL
PRICING AUTHORITY (NPPA)

  Department of Pharmaceutical sciences,
  Maharshi Dayanand University ,Rohtak
INTRODUCTION
 Drugs play an important role in the health of both people
  and the economy of a country
 People and Governments willing to spend money on drugs
  for many reasons so, it must be safe, effective and of good
  quality and used appropriately. Problems relating to drug
  safety and efficacy exist in many places around the world
  today in developing and developed countries .
 This means, that
  development, production, importation, exportation and
  subsequent distribution of drugs must be regulated to
  ensure that they meet prescribed standards.
  Therefore, effective drug regulation is required to ensure
  the safety, efficacy and quality of drugs as well as accuracy
  and appropriateness of the drugs.
The drug regulation consists

 1. Drug Laws
 2. Drug Regulatory Agencies
 3. Drug Regulatory Boards
 4. Quality Control
 5. Drug Information Centers etc.
DRUG REGULATORY SYSTEM IN INDIA
 DRUGS REGULATORY SYSTEM IN INDIA is governed
  by both Centre and State Governments under the Drugs &
  Cosmetics Act, 1940.
 MAIN BODIES
 CENTRAL DRUG STANDARD CONTROL
  ORGANIZATION (CDSCO)
 MINISTRY OF HEALTH AND FAMILY WELFARE
 INDIAN COUNCIL OF MEDICAL RESEARCH
  (ICMR)
 MINISTRY OF CHEMICAL AND FERTILIZER
 MINISTRY OF SCIENCE AND TECHNOLOGY
 MINISTRY OF COMMERCE.
MINISTRY OF CHEMICAL AND
FERTILIZER
 DEPARTMENT OF PHARMACEUITICAL
  ORGANIZATION AND STRUCTURE.
 NATIONAL PHARMACEUTICAL PRICING AUTHORITY
  (NPPA)
 ACTIVITIES AND RESPONSIBILITIES:
 All matters relating to NPPA including its functions of price
  control and monitoring.
 Responsible for development of infrastructure, manpower and
  skills for the pharmaceutical sector.
 Work for the promotion and coordination of basic, applied and
  other research in areas related to the pharmaceutical sector and
  for international co-operation in pharmaceutical research.
NATIONAL PHARMACEUTICAL PRICING
AUTHORITY (NPPA)
 The National Pharmaceutical Pricing Authority (NPPA), an
  independent body of experts in the Ministry of Chemicals
  and Fertilizers was formed by the Govt. of India at 1997.
 Resolution published in the Gazette of India No.159 dated
  29.08.97.
 The Resolution mentioned that the Government had been
  experiencing that the present mechanism for the fixation
  and revision of prices of bulk drugs and formulations was
  cumbersome, complicated and time consuming.
 In order to streamline and simplify the procedure and to
  bring about a greater degree of transparency as well as
  objectivity, an expert body should be constituted with the
  powers to fix prices and notify the changes therein, if
  any, of bulk drugs and formulations from time to
  time, under the Drugs (Price Control) Order.
 Powers were delegated to the NPPA by the Govt. of India
  vide Gazette Notification No. 637(E) dated 4th
  September, 1997
 NPPA is an organization of the Government of India which
  was established to fix/ revise the prices of controlled bulk
  drugs and formulations and to enforce
prices and availability of the medicines in the
  country, under the Drugs (Prices Control) Order, 1995.
 The organization is also entrusted with the task of
  recovering amounts overcharged by manufacturers for the
  controlled drugs from the consumers.
ORGANIZATION
 Chairman
 Member Secretary
 Advisor (Pricing)
 Bulk Drug Pricing
 Form-I,II & VI Examination
 Policy Matters
 Customs / Excise Issue
 Right to Information Bill
 Director (Formulation Division)
 Formulations Pricing
 (Form III & IV)
 Availability / Shortage of bulk drugs/formulations
 Production & Import/Export of drugs & formulations
 Parliament Questions / Assurance & VIP ref.
 Director (Monitoring & Enforcement Division)
 Monitoring & Enforcement of prices of bulk drugs &
    formulations, both Scheduled and non-scheduled
    Form-V examination
    Inclusion / Exclusion of drugs under DPCO,1995
    R&D aspects
    Pharma Index
 Director (Legal Division)
 Identified cases of overcharging on bulk drugs &
  formulations and related issues.
 Legal matters & follow up of the pending court cases.
 Any other references on the above
 Director (Admin Division)
 Establishment
 General Admn.
 Co-ordination
 Vigilance
FUNCTIONS OF NPPA
 To implement and enforce the provisions of the Drugs
  (Prices Control) Order in accordance with the powers
  delegated to it.
 To deal with all legal matters arising out of the decisions of
  the Authority;
 To monitor the availability of drugs, identify shortages, if
  any, and to take remedial steps;
 To collect/ maintain data on production, exports and
  imports, market share of individual companies, profitability
  of companies etc, for bulk drugs and formulations;
 To undertake and/ or sponsor relevant studies in respect of
  pricing of drugs/ pharmaceuticals;
 To recruit/ appoint the officers and other staff members of
  the Authority, as per rules and procedures laid down by the
  Government;
 To render advice to the Central Government on changes/
  revisions in the drug policy;
 To render assistance to the Central Government in the
  parliamentary matters relating to the drug pricing.
Nppa

Weitere ähnliche Inhalte

Was ist angesagt?

Drug Price Control Order -2013
Drug Price Control Order -2013Drug Price Control Order -2013
Drug Price Control Order -2013Ganesh Shevalkar
 
WHO GUIDELINES FOR TECH.TRANSFER SIDHANTA SAHU.
WHO GUIDELINES FOR TECH.TRANSFER SIDHANTA SAHU.WHO GUIDELINES FOR TECH.TRANSFER SIDHANTA SAHU.
WHO GUIDELINES FOR TECH.TRANSFER SIDHANTA SAHU.GvDurgamani
 
1. Unit I - new drug discovery and development.
1. Unit I - new drug discovery and development.1. Unit I - new drug discovery and development.
1. Unit I - new drug discovery and development.Audumbar Mali
 
National pharmaceutical pricing authority with drugs price control order (dpc...
National pharmaceutical pricing authority with drugs price control order (dpc...National pharmaceutical pricing authority with drugs price control order (dpc...
National pharmaceutical pricing authority with drugs price control order (dpc...Tushar Morankar
 
Central drug standard control organisation
Central drug standard control organisationCentral drug standard control organisation
Central drug standard control organisationbdvfgbdhg
 
Drug regulatory authority
Drug regulatory authority Drug regulatory authority
Drug regulatory authority Rahul Gawande
 
REGULATORY AFFAIRS ( IP-2 / UNIT 3 )
REGULATORY AFFAIRS ( IP-2 / UNIT 3 )REGULATORY AFFAIRS ( IP-2 / UNIT 3 )
REGULATORY AFFAIRS ( IP-2 / UNIT 3 )JAYACHANDRA AKUTHOTA
 
Import and registration of drugs
Import and registration of drugs Import and registration of drugs
Import and registration of drugs Kaushik D Kaushik
 
Certificate of pharmaceutical productCoPP.pptx
Certificate of pharmaceutical productCoPP.pptxCertificate of pharmaceutical productCoPP.pptx
Certificate of pharmaceutical productCoPP.pptxsneha_pharmacist
 
Indian regulatory requirements- CDSCO ( IP-2 / UNIT 5 )
Indian regulatory requirements- CDSCO ( IP-2 / UNIT 5 )Indian regulatory requirements- CDSCO ( IP-2 / UNIT 5 )
Indian regulatory requirements- CDSCO ( IP-2 / UNIT 5 )JAYACHANDRA AKUTHOTA
 
Drug and price controle order
Drug and price controle orderDrug and price controle order
Drug and price controle orderShubham Sharma
 
EXPORTS AND IMPORTS OF INDIAN PHARMACEUTICAL INDUSTRY
EXPORTS AND IMPORTS OF INDIAN PHARMACEUTICAL INDUSTRYEXPORTS AND IMPORTS OF INDIAN PHARMACEUTICAL INDUSTRY
EXPORTS AND IMPORTS OF INDIAN PHARMACEUTICAL INDUSTRYSai Datri Arige
 
Drug Price control order 2013
Drug Price control order 2013Drug Price control order 2013
Drug Price control order 2013Ramkrishna Bannai
 
Unit 4 chp 1 Pharmaceutical marketing channels.pdf
Unit 4 chp 1 Pharmaceutical marketing channels.pdfUnit 4 chp 1 Pharmaceutical marketing channels.pdf
Unit 4 chp 1 Pharmaceutical marketing channels.pdfRoshanKumarDubey2
 
Drug Price control order, 1995 (DPCO)
Drug Price control order, 1995 (DPCO)Drug Price control order, 1995 (DPCO)
Drug Price control order, 1995 (DPCO)rohit kamboj
 

Was ist angesagt? (20)

Drug Price Control Order -2013
Drug Price Control Order -2013Drug Price Control Order -2013
Drug Price Control Order -2013
 
WHO GUIDELINES FOR TECH.TRANSFER SIDHANTA SAHU.
WHO GUIDELINES FOR TECH.TRANSFER SIDHANTA SAHU.WHO GUIDELINES FOR TECH.TRANSFER SIDHANTA SAHU.
WHO GUIDELINES FOR TECH.TRANSFER SIDHANTA SAHU.
 
1. Unit I - new drug discovery and development.
1. Unit I - new drug discovery and development.1. Unit I - new drug discovery and development.
1. Unit I - new drug discovery and development.
 
National pharmaceutical pricing authority with drugs price control order (dpc...
National pharmaceutical pricing authority with drugs price control order (dpc...National pharmaceutical pricing authority with drugs price control order (dpc...
National pharmaceutical pricing authority with drugs price control order (dpc...
 
Ctd ppt
Ctd pptCtd ppt
Ctd ppt
 
Central drug standard control organisation
Central drug standard control organisationCentral drug standard control organisation
Central drug standard control organisation
 
Drug regulatory authority
Drug regulatory authority Drug regulatory authority
Drug regulatory authority
 
REGULATORY AFFAIRS ( IP-2 / UNIT 3 )
REGULATORY AFFAIRS ( IP-2 / UNIT 3 )REGULATORY AFFAIRS ( IP-2 / UNIT 3 )
REGULATORY AFFAIRS ( IP-2 / UNIT 3 )
 
Import and registration of drugs
Import and registration of drugs Import and registration of drugs
Import and registration of drugs
 
Regulatory affairs
Regulatory affairsRegulatory affairs
Regulatory affairs
 
The introduction of an orange book
The introduction of an orange bookThe introduction of an orange book
The introduction of an orange book
 
Certificate of pharmaceutical productCoPP.pptx
Certificate of pharmaceutical productCoPP.pptxCertificate of pharmaceutical productCoPP.pptx
Certificate of pharmaceutical productCoPP.pptx
 
Indian regulatory requirements- CDSCO ( IP-2 / UNIT 5 )
Indian regulatory requirements- CDSCO ( IP-2 / UNIT 5 )Indian regulatory requirements- CDSCO ( IP-2 / UNIT 5 )
Indian regulatory requirements- CDSCO ( IP-2 / UNIT 5 )
 
Drug and price controle order
Drug and price controle orderDrug and price controle order
Drug and price controle order
 
Dpco as per pci
Dpco as per pciDpco as per pci
Dpco as per pci
 
Granularity of TT Process.pdf
Granularity of TT Process.pdfGranularity of TT Process.pdf
Granularity of TT Process.pdf
 
EXPORTS AND IMPORTS OF INDIAN PHARMACEUTICAL INDUSTRY
EXPORTS AND IMPORTS OF INDIAN PHARMACEUTICAL INDUSTRYEXPORTS AND IMPORTS OF INDIAN PHARMACEUTICAL INDUSTRY
EXPORTS AND IMPORTS OF INDIAN PHARMACEUTICAL INDUSTRY
 
Drug Price control order 2013
Drug Price control order 2013Drug Price control order 2013
Drug Price control order 2013
 
Unit 4 chp 1 Pharmaceutical marketing channels.pdf
Unit 4 chp 1 Pharmaceutical marketing channels.pdfUnit 4 chp 1 Pharmaceutical marketing channels.pdf
Unit 4 chp 1 Pharmaceutical marketing channels.pdf
 
Drug Price control order, 1995 (DPCO)
Drug Price control order, 1995 (DPCO)Drug Price control order, 1995 (DPCO)
Drug Price control order, 1995 (DPCO)
 

Ähnlich wie Nppa

National Pharmaceutical Pricing Authority (NPPA) & Drug Price Control Order (...
National Pharmaceutical Pricing Authority (NPPA) & Drug Price Control Order (...National Pharmaceutical Pricing Authority (NPPA) & Drug Price Control Order (...
National Pharmaceutical Pricing Authority (NPPA) & Drug Price Control Order (...Dr. Ambekar Abdul Wahid
 
Regulatory authorities of copyright liasion
Regulatory authorities of copyright liasionRegulatory authorities of copyright liasion
Regulatory authorities of copyright liasionRAMZAHASHMI
 
Bodies regulating indian pharmaceutical sector, cdsco
Bodies regulating indian pharmaceutical sector, cdscoBodies regulating indian pharmaceutical sector, cdsco
Bodies regulating indian pharmaceutical sector, cdscochiranjibi68
 
Nppa,gst& its impact
Nppa,gst& its impactNppa,gst& its impact
Nppa,gst& its impactRituJain142
 
3206 law & ethics manik
3206 law & ethics  manik3206 law & ethics  manik
3206 law & ethics manikImran Nur Manik
 
DGDA-DIU-akt.pptxMajor steps of a Drug Registration
DGDA-DIU-akt.pptxMajor steps of a Drug RegistrationDGDA-DIU-akt.pptxMajor steps of a Drug Registration
DGDA-DIU-akt.pptxMajor steps of a Drug RegistrationUSAYATUNMAHERA2
 
Regulatory affairs - industrial pharmacy II
Regulatory affairs - industrial pharmacy IIRegulatory affairs - industrial pharmacy II
Regulatory affairs - industrial pharmacy IIJafarali Masi
 
National pharmaceutical pricing authority.pdf
National pharmaceutical pricing authority.pdfNational pharmaceutical pricing authority.pdf
National pharmaceutical pricing authority.pdfDarshanpatel609504
 
OVERVIEW OF DRUG REGULATORY AGENCIES IN INDIA, USA, EUROPE AND JAPAN
OVERVIEW OF DRUG REGULATORY AGENCIES IN INDIA, USA, EUROPE AND JAPAN OVERVIEW OF DRUG REGULATORY AGENCIES IN INDIA, USA, EUROPE AND JAPAN
OVERVIEW OF DRUG REGULATORY AGENCIES IN INDIA, USA, EUROPE AND JAPAN Arul Packiadhas
 
Asu drug regulations in india
Asu drug regulations in indiaAsu drug regulations in india
Asu drug regulations in indiaARAVIND R
 
pros & cons Of Pharmaceutical Industry In INDIA-2011
pros & cons Of Pharmaceutical Industry In INDIA-2011pros & cons Of Pharmaceutical Industry In INDIA-2011
pros & cons Of Pharmaceutical Industry In INDIA-2011Raghava Reddy
 
Regulatory agencies
Regulatory agenciesRegulatory agencies
Regulatory agenciesShaik Sana
 
Drug regulatory agencies
Drug regulatory agenciesDrug regulatory agencies
Drug regulatory agenciesANANT NAG
 

Ähnlich wie Nppa (20)

National Pharmaceutical Pricing Authority (NPPA) & Drug Price Control Order (...
National Pharmaceutical Pricing Authority (NPPA) & Drug Price Control Order (...National Pharmaceutical Pricing Authority (NPPA) & Drug Price Control Order (...
National Pharmaceutical Pricing Authority (NPPA) & Drug Price Control Order (...
 
Drug pricing policy india
Drug pricing policy indiaDrug pricing policy india
Drug pricing policy india
 
Drug price
Drug priceDrug price
Drug price
 
Regulatory authorities of copyright liasion
Regulatory authorities of copyright liasionRegulatory authorities of copyright liasion
Regulatory authorities of copyright liasion
 
Ska
SkaSka
Ska
 
Bodies regulating indian pharmaceutical sector, cdsco
Bodies regulating indian pharmaceutical sector, cdscoBodies regulating indian pharmaceutical sector, cdsco
Bodies regulating indian pharmaceutical sector, cdsco
 
Regulatory affairs
Regulatory affairsRegulatory affairs
Regulatory affairs
 
Regulatory Issues for ASU.ppt by Dr.U.Srinivasa
Regulatory Issues for ASU.ppt by Dr.U.SrinivasaRegulatory Issues for ASU.ppt by Dr.U.Srinivasa
Regulatory Issues for ASU.ppt by Dr.U.Srinivasa
 
Nppa,gst& its impact
Nppa,gst& its impactNppa,gst& its impact
Nppa,gst& its impact
 
3206 law & ethics manik
3206 law & ethics  manik3206 law & ethics  manik
3206 law & ethics manik
 
DGDA-DIU-akt.pptxMajor steps of a Drug Registration
DGDA-DIU-akt.pptxMajor steps of a Drug RegistrationDGDA-DIU-akt.pptxMajor steps of a Drug Registration
DGDA-DIU-akt.pptxMajor steps of a Drug Registration
 
Regulatory affairs - industrial pharmacy II
Regulatory affairs - industrial pharmacy IIRegulatory affairs - industrial pharmacy II
Regulatory affairs - industrial pharmacy II
 
National pharmaceutical pricing authority.pdf
National pharmaceutical pricing authority.pdfNational pharmaceutical pricing authority.pdf
National pharmaceutical pricing authority.pdf
 
OVERVIEW OF DRUG REGULATORY AGENCIES IN INDIA, USA, EUROPE AND JAPAN
OVERVIEW OF DRUG REGULATORY AGENCIES IN INDIA, USA, EUROPE AND JAPAN OVERVIEW OF DRUG REGULATORY AGENCIES IN INDIA, USA, EUROPE AND JAPAN
OVERVIEW OF DRUG REGULATORY AGENCIES IN INDIA, USA, EUROPE AND JAPAN
 
Asu drug regulations in india
Asu drug regulations in indiaAsu drug regulations in india
Asu drug regulations in india
 
pros & cons Of Pharmaceutical Industry In INDIA-2011
pros & cons Of Pharmaceutical Industry In INDIA-2011pros & cons Of Pharmaceutical Industry In INDIA-2011
pros & cons Of Pharmaceutical Industry In INDIA-2011
 
Regulatory Issues
Regulatory IssuesRegulatory Issues
Regulatory Issues
 
Regulatory agencies
Regulatory agenciesRegulatory agencies
Regulatory agencies
 
Drug regulatory agencies
Drug regulatory agenciesDrug regulatory agencies
Drug regulatory agencies
 
Drug Regulatory Affairs (DRA)
Drug Regulatory Affairs (DRA)Drug Regulatory Affairs (DRA)
Drug Regulatory Affairs (DRA)
 

Mehr von bdvfgbdhg

Scale up and post approval changes(supac)
Scale up and post approval changes(supac)Scale up and post approval changes(supac)
Scale up and post approval changes(supac)bdvfgbdhg
 
Priscription drug user free act......sn
Priscription drug user free act......snPriscription drug user free act......sn
Priscription drug user free act......snbdvfgbdhg
 
Medical device
Medical deviceMedical device
Medical devicebdvfgbdhg
 
Labeling in india
Labeling in indiaLabeling in india
Labeling in indiabdvfgbdhg
 
Registration procedure of drugs in european union
Registration procedure of drugs in european unionRegistration procedure of drugs in european union
Registration procedure of drugs in european unionbdvfgbdhg
 
Bulk active post approval changes
Bulk active post approval changesBulk active post approval changes
Bulk active post approval changesbdvfgbdhg
 
Drug abuse & control act 1970 ppt dra2
Drug abuse & control act 1970 ppt dra2Drug abuse & control act 1970 ppt dra2
Drug abuse & control act 1970 ppt dra2bdvfgbdhg
 
Post marketing servillence
Post marketing servillencePost marketing servillence
Post marketing servillencebdvfgbdhg
 
Post marketing servillence
Post marketing servillencePost marketing servillence
Post marketing servillencebdvfgbdhg
 

Mehr von bdvfgbdhg (10)

Snda
SndaSnda
Snda
 
Scale up and post approval changes(supac)
Scale up and post approval changes(supac)Scale up and post approval changes(supac)
Scale up and post approval changes(supac)
 
Priscription drug user free act......sn
Priscription drug user free act......snPriscription drug user free act......sn
Priscription drug user free act......sn
 
Medical device
Medical deviceMedical device
Medical device
 
Labeling in india
Labeling in indiaLabeling in india
Labeling in india
 
Registration procedure of drugs in european union
Registration procedure of drugs in european unionRegistration procedure of drugs in european union
Registration procedure of drugs in european union
 
Bulk active post approval changes
Bulk active post approval changesBulk active post approval changes
Bulk active post approval changes
 
Drug abuse & control act 1970 ppt dra2
Drug abuse & control act 1970 ppt dra2Drug abuse & control act 1970 ppt dra2
Drug abuse & control act 1970 ppt dra2
 
Post marketing servillence
Post marketing servillencePost marketing servillence
Post marketing servillence
 
Post marketing servillence
Post marketing servillencePost marketing servillence
Post marketing servillence
 

Nppa

  • 1. NATIONAL PHARMACEUTICAL PRICING AUTHORITY (NPPA) Department of Pharmaceutical sciences, Maharshi Dayanand University ,Rohtak
  • 2. INTRODUCTION  Drugs play an important role in the health of both people and the economy of a country  People and Governments willing to spend money on drugs for many reasons so, it must be safe, effective and of good quality and used appropriately. Problems relating to drug safety and efficacy exist in many places around the world today in developing and developed countries .  This means, that development, production, importation, exportation and subsequent distribution of drugs must be regulated to ensure that they meet prescribed standards. Therefore, effective drug regulation is required to ensure the safety, efficacy and quality of drugs as well as accuracy and appropriateness of the drugs.
  • 3. The drug regulation consists  1. Drug Laws  2. Drug Regulatory Agencies  3. Drug Regulatory Boards  4. Quality Control  5. Drug Information Centers etc.
  • 4. DRUG REGULATORY SYSTEM IN INDIA  DRUGS REGULATORY SYSTEM IN INDIA is governed by both Centre and State Governments under the Drugs & Cosmetics Act, 1940.  MAIN BODIES  CENTRAL DRUG STANDARD CONTROL ORGANIZATION (CDSCO)  MINISTRY OF HEALTH AND FAMILY WELFARE  INDIAN COUNCIL OF MEDICAL RESEARCH (ICMR)  MINISTRY OF CHEMICAL AND FERTILIZER  MINISTRY OF SCIENCE AND TECHNOLOGY  MINISTRY OF COMMERCE.
  • 5. MINISTRY OF CHEMICAL AND FERTILIZER  DEPARTMENT OF PHARMACEUITICAL ORGANIZATION AND STRUCTURE.  NATIONAL PHARMACEUTICAL PRICING AUTHORITY (NPPA)  ACTIVITIES AND RESPONSIBILITIES:  All matters relating to NPPA including its functions of price control and monitoring.  Responsible for development of infrastructure, manpower and skills for the pharmaceutical sector.  Work for the promotion and coordination of basic, applied and other research in areas related to the pharmaceutical sector and for international co-operation in pharmaceutical research.
  • 6. NATIONAL PHARMACEUTICAL PRICING AUTHORITY (NPPA)  The National Pharmaceutical Pricing Authority (NPPA), an independent body of experts in the Ministry of Chemicals and Fertilizers was formed by the Govt. of India at 1997.  Resolution published in the Gazette of India No.159 dated 29.08.97.  The Resolution mentioned that the Government had been experiencing that the present mechanism for the fixation and revision of prices of bulk drugs and formulations was cumbersome, complicated and time consuming.
  • 7.  In order to streamline and simplify the procedure and to bring about a greater degree of transparency as well as objectivity, an expert body should be constituted with the powers to fix prices and notify the changes therein, if any, of bulk drugs and formulations from time to time, under the Drugs (Price Control) Order.  Powers were delegated to the NPPA by the Govt. of India vide Gazette Notification No. 637(E) dated 4th September, 1997  NPPA is an organization of the Government of India which was established to fix/ revise the prices of controlled bulk drugs and formulations and to enforce
  • 8. prices and availability of the medicines in the country, under the Drugs (Prices Control) Order, 1995.  The organization is also entrusted with the task of recovering amounts overcharged by manufacturers for the controlled drugs from the consumers.
  • 9. ORGANIZATION  Chairman  Member Secretary  Advisor (Pricing)  Bulk Drug Pricing  Form-I,II & VI Examination  Policy Matters  Customs / Excise Issue  Right to Information Bill  Director (Formulation Division)  Formulations Pricing  (Form III & IV)
  • 10.  Availability / Shortage of bulk drugs/formulations  Production & Import/Export of drugs & formulations  Parliament Questions / Assurance & VIP ref.  Director (Monitoring & Enforcement Division)  Monitoring & Enforcement of prices of bulk drugs & formulations, both Scheduled and non-scheduled  Form-V examination  Inclusion / Exclusion of drugs under DPCO,1995  R&D aspects  Pharma Index
  • 11.  Director (Legal Division)  Identified cases of overcharging on bulk drugs & formulations and related issues.  Legal matters & follow up of the pending court cases.  Any other references on the above  Director (Admin Division)  Establishment  General Admn.  Co-ordination  Vigilance
  • 12. FUNCTIONS OF NPPA  To implement and enforce the provisions of the Drugs (Prices Control) Order in accordance with the powers delegated to it.  To deal with all legal matters arising out of the decisions of the Authority;  To monitor the availability of drugs, identify shortages, if any, and to take remedial steps;  To collect/ maintain data on production, exports and imports, market share of individual companies, profitability of companies etc, for bulk drugs and formulations;
  • 13.  To undertake and/ or sponsor relevant studies in respect of pricing of drugs/ pharmaceuticals;  To recruit/ appoint the officers and other staff members of the Authority, as per rules and procedures laid down by the Government;  To render advice to the Central Government on changes/ revisions in the drug policy;  To render assistance to the Central Government in the parliamentary matters relating to the drug pricing.